logo
#

Latest news with #Colgate-Palmolive

Colgate-Palmolive Announces Executive Leadership Appointments
Colgate-Palmolive Announces Executive Leadership Appointments

Business Wire

time3 days ago

  • Business
  • Business Wire

Colgate-Palmolive Announces Executive Leadership Appointments

NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL) today announced several executive leadership appointments that will take effect June 16, 2025. 50, will join Colgate-Palmolive in the newly created leadership role of Chief Operating Officer, Americas, overseeing the North America and Latin America regions. Mr. Grant is a recognized industry leader with a proven track record of achieving strong results. Mr. Grant joins Colgate-Palmolive from Group Danone, where he most recently held the position of Group Deputy CEO, CEO Americas and EVP Dairy, Plant-Based and Global Sales. Prior to Danone, Mr. Grant spent nearly 20 years with The Coca-Cola Company, where he held various leadership roles of increasing responsibility in category leadership, commercial and general management. Panagiotis (Panos) Tsourapas, 60, has been named Chief Operating Officer, Europe, Asia Pacific, Africa Eurasia, Skin Health & Global Customer Development. Mr. Tsourapas has demonstrated his leadership across a global career with Colgate-Palmolive in Customer Development, Marketing, general management and senior leadership roles. In 2020, Mr. Tsourapas was promoted to Group President, Latin America, Asia Pacific and Africa Eurasia and, in 2022 and 2024, his role was broadened to include Europe and Global Customer Development, respectively. John Hazlin, 55, has been named Chief Growth Officer. Mr. Hazlin will be responsible for leading the implementation of the 2030 Strategic Plan including initiatives focused on enterprise transformation and peer-leading capabilities. Mr. Hazlin will also be responsible for setting direction for our global categories and for the global growth functions, including Analytics, Design, Digital, Research & Development and Supply Chain. Currently President of the Company's Hill's Pet Nutrition business, Mr. Hazlin will continue to lead that organization until his successor is named. Stanley (Stan) Sutula III, 59, Chief Financial Officer, will now have additional responsibility for the strategic oversight of Global Information Technology and Mergers & Acquisitions. These areas have long-term strategic importance to the Company's growth and strategy, and Mr. Sutula's deep background and experience in driving transformation with technology and M&A make him an ideal choice for these added responsibilities. Prabha Parameswaran, 66, has been named Vice Chair. In this capacity, Ms. Parameswaran will collaborate closely with the leadership team to guide key enterprise priorities, which include the strategic focus on innovation, omni demand generation and scaling AI across the organization. She will continue to lead our sustainability and social impact strategy. Ms. Parameswaran, who had been Group President, Growth and Strategy, will serve as Vice Chair until her planned retirement on October 1, 2025. All of these leaders report to Noel Wallace, Chairman, President and Chief Executive Officer. Mr. Wallace commented, 'We continue to build capabilities, strengthen our team and refine our organizational structure to ensure we keep winning in the global markets and categories where we compete. As we move ahead with our 2030 strategy, this strong mix of leaders will build on our momentum to ensure we are positioned to reach our ambitious growth goals.' * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children's oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.8 billion children and their families since 1991. For more information about Colgate's global business and how we are building a future to smile about, visit CL-C

Axis Securities maintains Buy on Colgate-Palmolive (India), lowers target price to Rs 2,830
Axis Securities maintains Buy on Colgate-Palmolive (India), lowers target price to Rs 2,830

Time of India

time6 days ago

  • Business
  • Time of India

Axis Securities maintains Buy on Colgate-Palmolive (India), lowers target price to Rs 2,830

Axis Securities maintains the Buy call on Colgate-Palmolive (India) with a revised target price of Rs 2,830 (earlier Rs 2,950}. The current market price of Colgate-Palmolive (India) is Rs 2481.6. Colgate-Palmolive, incorporated in 1937, is a Large Cap company with a market cap of Rs 67436.12 crore, operating in the FMCG sector. Colgate-Palmolive India 's key products/revenue segments include Personal Care, Service Income and Scrap for the year ending 31-Mar-2024. Financials For the quarter ended 31-03-2025, the company has reported a Standalone Total Income of Rs 1481.57 crore, down -.05 % from last quarter Total Income of Rs 1482.24 crore and down -2.06 % from last year same quarter Total Income of Rs 1512.66 crore. The company has reported net profit after tax of Rs 355.00 crore in the latest quarter. The company's top management includes Deoras, Narasimhan, Mr.M S Jacob, Sharma, Natarajan, Pant, Bhushan, Gupta, Kripalu. Company has SRBC & Co LLP as its auditors. As on 31-03-2025, the company has a total of 27 crore shares outstanding. Investment Rationale Axis Securities appreciates the company's overall long-term strategy, which focuses on driving top-line growth through initiatives such as: 1) Launching science-based premium products to enhance overall realisations, 2) Developing the category by increasing awareness through marketing initiatives, 3) Increasing the frequency of consumption and penetration in rural markets, and 4) Expanding the personal care portfolio to mitigate risks associated with the slow-growing oral care category. Moreover, demand environment is likely to improve in the coming quarters (H2FY26), and the stock price correction of 35% from the latest high all provides a huge margin of safety. Hence, the brokerage maintains its BUY rating with a revised target price of Rs 2,830 /share, implying an upside potential of 14% from the CMP.

Over two-thirds of urban Indians face financial stress, slowing demand for Oral Care products: Colgate-Palmolive CEO Prabha Narasimhan
Over two-thirds of urban Indians face financial stress, slowing demand for Oral Care products: Colgate-Palmolive CEO Prabha Narasimhan

Time of India

time23-05-2025

  • Business
  • Time of India

Over two-thirds of urban Indians face financial stress, slowing demand for Oral Care products: Colgate-Palmolive CEO Prabha Narasimhan

Colgate-Palmolive India managing director and CEO Prabha Narasimhan on Thursday said more than two-thirds of urban Indian consumers are facing financial stress, leading to a slowdown in overall consumer demand, including for oral care products. While 30% urban consumers are resilient, the rest are delaying purchases of daily household and personal products, she said. "The bottom 70% of urban under pressure, and that pressure is leading to an impact on oral health volumes, as much as it is leading to impact on various other categories (and) FMCG volume," Narasimhan told analysts at an earnings call after the firm's March quarter results. She expects a revival in the second half of FY26. "Rural (India) continues to look like a real bright spot. So, we see this getting sequentially better, and particularly towards the back half of this year," she said. The company behind the eponymous toothpaste brand controls half the oral care segment in the country. Consumers are still not shifting to lower-priced products and are instead extending their product usage a little longer, Narasimhan told analysts. "Consumers don't stop buying or using toothpaste. The way to adjust how much you spend on this category is actually by adjusting how much toothpaste you put on your toothbrush, and therefore the titration downwards of that usage is what leads to a decline in volume," she explained. "We are not actually seeing downtrading in the market, and the reason for the slowing volume growth is actually consumers titrating the amount of toothpaste that they use. So, it's not that consumers drop out of the category. The overall penetration of the toothpaste category remains at its near universal level. It doesn't wobble." Narasimhan expects the macro indicators and the company's interventions through new innovations to help reverse the slowdown in demand. Colgate-Palmolive on Wednesday reported a 2% year-on-year fall in its revenue for the quarter ended March, while its net profit declined 7%. Demand for daily groceries and other household and personal products worsened to a two-year low during the March quarter, indicating delayed turnaround for India's fast-moving consumer goods (FMCG) sector. Global research firm Kantar said FMCG volume sales growth in the January-March quarter was 3.5%, slowest since the 2023 March quarter. A year ago, the market had grown 5.5% during the same quarter. Earlier this year, Colgate had said India was the most prominent market globally to experience fierce competition among consumer goods companies, marked by steep discounting to attract urban shoppers.

Colgate tanks as Q4 PAT slides 7% YoY to Rs 355 cr; declares dividend of Rs 27/sh
Colgate tanks as Q4 PAT slides 7% YoY to Rs 355 cr; declares dividend of Rs 27/sh

Business Standard

time22-05-2025

  • Business
  • Business Standard

Colgate tanks as Q4 PAT slides 7% YoY to Rs 355 cr; declares dividend of Rs 27/sh

Colgate-Palmolive (India) tanked 4.55% to Rs 2,537.55 after the company's standalone net profit declined 6.53% to Rs 355 crore in Q4 FY25 as against Rs 379.82 crore posted in Q4 FY24. Revenue from operations fell 1.93% year on year (YoY) to Rs 1,452 crore in the quarter ended 31 March 2025. Profit before tax (PBT) stood at Rs 477.62 crore in the fourth quarter of FY25, down 6.59% from Rs 511.36 crore posted in the same period a year ago. Total expense rose 0.26% year on year to Rs 1,004 crore during the quarter. The cost of raw materials consumed stood at Rs 386.47 crore (down 0.32% YoY), while employee benefits expense was at Rs 107.27 crore (up 7.35% YoY) during the period under review. On a full year basis, the companys net profit rose 8.54% to Rs 1,436.8 crore on 6.28% increase in revenue from operations to Rs 5,999.2 crore in FY25 over FY24. During this quarter, Colgate has relaunched its flagship product, Colgate Strong Teeth Toothpaste, offering a superior sensory experience in key markets. The toothpaste is enriched with Colgate World of Care Arginine technology, providing a calcium boost that makes teeth 2X stronger. Additionally, the company introduced Colgate Total Plaque Release Toothpaste, featuring advanced Amino Foam and Zinc technology. This new formula works deep along the gumline, removing 3X more plaque and strengthening gums for improved oral health. Prabha Narasimhan, Managing Director & CEO of Colgate-Palmolive (India), said, In FY25, the company achieved a 6.3% year-on-year increase in topline revenue, with Toothpaste recording mid-single-digit value growth. The operating environment proved challenging in the second half of the year, primarily due to softening urban demand and intensified competition, which impacted Q4 performance. Despite these headwinds, we remain steadfast in our commitment to our strategic priorities. Our Toothbrush portfolio delivered another year of robust growth. Our margin profile remains healthy and resilient, underpinned by effective execution of our Funding The Growth program. We continue to capitalize on our solid margin position by reinvesting in the business. Looking forward, while we anticipate continued near-term macro headwinds, we expect to see a gradual recovery in market conditions in the latter part of the year. Meanwhile, the board has declared a second interim dividend of Rs 27/- per share, with a face value of Re. 1 each. The total dividend payout to shareholders will amount to Rs 734 crore and is scheduled to be paid on or after 16 June 2025, to shareholders whose names appear on the register of members of the company as of 28 May 2025. The total dividend for the financial year 2024-25 will be Rs. 51/- per share. Colgate-Palmolive (India) provides oral care products under the Colgate brand. It also provides personal care products under the 'Palmolive' brand name.

Colgate-Palmolive shares drop 6% after Q4 earnings; profit, revenue slip
Colgate-Palmolive shares drop 6% after Q4 earnings; profit, revenue slip

Business Standard

time22-05-2025

  • Business
  • Business Standard

Colgate-Palmolive shares drop 6% after Q4 earnings; profit, revenue slip

Shares of Colgate-Palmolive (India) fell nearly 6 per cent on Thursday after it posted a 6.5 per cent decline in its net profit for the fourth quarter of the previous financial year (Q4FY25) The consumer goods firm's stock fell as much as 5.88 per cent during the day to ₹2,599 per share. The stock pared losses to trade 5.7 per cent lower at ₹2,507 apiece, compared to a 0.89 per cent decline in Nifty 50 as of 10:25 AM. Shares of the company have fallen over 8 per cent from their recent highs of ₹2,747, which it hit earlier this month. The counter has fallen 6.5 per cent this year, compared to a 3.7 per cent advance in the benchmark Nifty 50. Colgate-Palmolive has a total market capitalisation of ₹68,178.64 crore, according to BSE data. Colgate-Palmolive (India) Q4FY25 results The company's net profit declined by 6.5 per cent to ₹355 crore, compared to ₹380 crore in the year-ago period. Meanwhile, it reported a 1.9 per cent decline in revenue from operations at ₹1,462 crore, compared to ₹1,490 crore in the same period last year. On the operational front, earnings before interest, tax, depreciation, and amortisation (Ebitda) fell by 6.4 per cent to ₹498.1 crore, as against ₹532.2 crore a year ago. The Ebitda margin stood at 34.1 per cent, down from 35.7 per cent in the corresponding period of the previous year. For the full year, net profit rose by 8.55 per cent to ₹1,436.81 crore in the year ended March 2025, as against ₹1,323.66 crore in the previous financial year ended March 2024. Revenue from operations increased by 6.29 per cent to ₹5,999.20 crore in the year ended March 2025. About Colgate-Palmolive (India) The company is a subsidiary of Colgate-Palmolive USA and is a leading provider of scientifically proven oral care products. The range includes toothpastes, toothpowder, toothbrushes and mouthwashes under the 'Colgate' brand as well as a specialised range of dental therapies under the banner of Colgate Oral Pharmaceuticals.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store